Hyaluronic acid (HA) is naturally present in the highest concentrations in fluids in the eyes and joints. The hyaluronic acid for medicine is either extracted from rooster combs or biologically synthesized in bacteria. Hyaluronic acid is a glycosaminoglycan that helps in transportation of nutrients through the body and facilitate water retention in body tissue. It is naturally found in body; in joints, eye cavity, and immune system. Hyaluronic acid is used for various joint disorders, including osteoarthritis and during certain eye surgeries including cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. It is injected into the eye during the procedure to help replace natural fluids. It can be taken by mouth or injected into the affected joint.
The global hyaluronic acid injections market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global hyaluronic acid injections market segmentation is based on product types (single-injection cycle products, three-injection cycle products, five- injection cycle products), applications (osteoarthritis, ophthalmic, dermal fillers, vesicoureteral reflux).
The global hyaluronic acid injections market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global hyaluronic acid injections market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global hyaluronic acid injections market and included in this report are Allergan,Inc., Anika Therapeutics, Inc., Merz Aesthetics, Inc., Sanofi (Genzeyme) and Seikagaku.